Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1807 1
1808 2
1818 1
1826 1
1844 1
1912 1
1931 1
1932 2
1937 1
1940 1
1944 1
1945 2
1946 4
1947 9
1948 10
1949 16
1950 28
1951 27
1952 19
1953 20
1954 18
1955 15
1956 19
1957 16
1958 18
1959 17
1960 12
1961 16
1962 15
1963 12
1964 22
1965 22
1966 16
1967 12
1968 20
1969 27
1970 18
1971 29
1972 23
1973 23
1974 30
1975 28
1976 31
1977 53
1978 34
1979 29
1980 36
1981 53
1982 51
1983 60
1984 75
1985 83
1986 102
1987 83
1988 90
1989 122
1990 97
1991 113
1992 123
1993 116
1994 132
1995 122
1996 115
1997 122
1998 149
1999 129
2000 158
2001 150
2002 144
2003 163
2004 177
2005 171
2006 198
2007 185
2008 210
2009 210
2010 248
2011 280
2012 313
2013 283
2014 277
2015 305
2016 268
2017 262
2018 272
2019 258
2020 312
2021 342
2022 309
2023 261
2024 197

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,000 results

Results by year

Filters applied: . Clear all
Page 1
Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, Johansson M, Brennan P, Key T, Lewis SJ, Martin RM, Murphy N, Platz EA, Travis R, Yarmolinsky J, Zuber V, Martin P, Katsoulis M, Freisling H, Nøst TH, Schulze MB, Dossus L, Hung RJ, Amos CI, Ahola-Olli A, Palaniswamy S, Männikkö M, Auvinen J, Herzig KH, Keinänen-Kiukaanniemi S, Lehtimäki T, Salomaa V, Raitakari O, Salmi M, Jalkanen S; PRACTICAL consortium; Jarvelin MR, Dehghan A, Tsilidis KK. Bouras E, et al. Among authors: martin p. BMC Med. 2022 Jan 11;20(1):3. doi: 10.1186/s12916-021-02193-0. BMC Med. 2022. PMID: 35012533 Free PMC article.
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Laetsch TW, Maude SL, Rives S, Hiramatsu H, Bittencourt H, Bader P, Baruchel A, Boyer M, De Moerloose B, Qayed M, Buechner J, Pulsipher MA, Myers GD, Stefanski HE, Martin PL, Nemecek E, Peters C, Yanik G, Khaw SL, Davis KL, Krueger J, Balduzzi A, Boissel N, Tiwari R, O'Donovan D, Grupp SA. Laetsch TW, et al. Among authors: martin pl. J Clin Oncol. 2023 Mar 20;41(9):1664-1669. doi: 10.1200/JCO.22.00642. Epub 2022 Nov 18. J Clin Oncol. 2023. PMID: 36399695 Free PMC article. Clinical Trial.
Vingt ans de néphrologie à Genève.
Martin PY, De Seigneux S, Fakhouri F. Martin PY, et al. Rev Med Suisse. 2022 Mar 2;18(771):355-356. doi: 10.53738/REVMED.2022.18.771.355. Rev Med Suisse. 2022. PMID: 35235257 French. No abstract available.
Acalabrutinib in treatment-naive chronic lymphocytic leukemia.
Byrd JC, Woyach JA, Furman RR, Martin P, O'Brien S, Brown JR, Stephens DM, Barrientos JC, Devereux S, Hillmen P, Pagel JM, Hamdy A, Izumi R, Patel P, Wang MH, Jain N, Wierda WG. Byrd JC, et al. Among authors: martin p. Blood. 2021 Jun 17;137(24):3327-3338. doi: 10.1182/blood.2020009617. Blood. 2021. PMID: 33786588 Free PMC article. Clinical Trial.
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.
Bleakley M, Sehgal A, Seropian S, Biernacki MA, Krakow EF, Dahlberg A, Persinger H, Hilzinger B, Martin PJ, Carpenter PA, Flowers ME, Voutsinas J, Gooley TA, Loeb K, Wood BL, Heimfeld S, Riddell SR, Shlomchik WD. Bleakley M, et al. Among authors: martin pj. J Clin Oncol. 2022 Apr 10;40(11):1174-1185. doi: 10.1200/JCO.21.01755. Epub 2022 Jan 10. J Clin Oncol. 2022. PMID: 35007144 Free PMC article. Clinical Trial.
Cytomegalovirus breakthrough and resistance during letermovir prophylaxis.
Perchetti GA, Biernacki MA, Xie H, Castor J, Joncas-Schronce L, Ueda Oshima M, Kim Y, Jerome KR, Sandmaier BM, Martin PJ, Boeckh M, Greninger AL, Zamora D. Perchetti GA, et al. Among authors: martin pj. Bone Marrow Transplant. 2023 Apr;58(4):430-436. doi: 10.1038/s41409-023-01920-w. Epub 2023 Jan 24. Bone Marrow Transplant. 2023. PMID: 36693927
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC.
Tu E, McGlinchey K, Wang J, Martin P, Ching SL, Floc'h N, Kurasawa J, Starrett JH, Lazdun Y, Wetzel L, Nuttall B, Ng FS, Coffman KT, Smith PD, Politi K, Cooper ZA, Streicher K. Tu E, et al. Among authors: martin p. JCI Insight. 2022 Feb 8;7(3):e142843. doi: 10.1172/jci.insight.142843. JCI Insight. 2022. PMID: 35132961 Free PMC article.
CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.
Blanco-Domínguez R, de la Fuente H, Rodríguez C, Martín-Aguado L, Sánchez-Díaz R, Jiménez-Alejandre R, Rodríguez-Arabaolaza I, Curtabbi A, García-Guimaraes MM, Vera A, Rivero F, Cuesta J, Jiménez-Borreguero LJ, Cecconi A, Duran-Cambra A, Taurón M, Alonso J, Bueno H, Villalba-Orero M, Enríquez JA, Robson SC, Alfonso F, Sánchez-Madrid F, Martínez-González J, Martín P. Blanco-Domínguez R, et al. Among authors: martin p. J Clin Invest. 2022 Nov 1;132(21):e152418. doi: 10.1172/JCI152418. J Clin Invest. 2022. PMID: 36066993 Free PMC article.
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma.
Lynch RC, Ujjani CS, Poh C, Warren EH, Smith SD, Shadman M, Till B, Raghunathan VM, Alig S, Alizadeh AA, Gulhane A, Chen DL, Tseng Y, Coye H, Shelby M, Ottemiller S, Keo S, Verni K, Du H, Vandermeer J, Gaston A, Rasmussen H, Martin P, Marzbani E, Voutsinas J, Gopal AK. Lynch RC, et al. Among authors: martin p. Blood. 2023 May 25;141(21):2576-2586. doi: 10.1182/blood.2022019254. Blood. 2023. PMID: 36913694 Free PMC article. Clinical Trial.
8,000 results